|
Market Closed -
Bombay S.E.
18:02:27 13/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 182.25 INR | +4.98% |
|
+5.13% | +7.14% |
| Market Cap | 579M 6.07M 5.26M 4.93M 4.5M 8.46M 8.6M 58.07M 22.67M 290M 22.79M 22.29M 967M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 547M 5.73M 4.97M 4.66M 4.25M 7.99M 8.12M 54.82M 21.4M 274M 21.51M 21.04M 913M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | +4.98% | ||
| 1 week | +5.13% | ||
| Current month | +3.02% | ||
| 1 month | +4.20% | ||
| 3 months | +45.92% | ||
| 6 months | +27.54% | ||
| Current year | +7.14% |
| 1 week | 172 | 184 | |
| 1 month | 167.05 | 184 | |
| Current year | 100.1 | 184 | |
| 1 year | 100.1 | 220 | |
| 3 years | 100.1 | 398 | |
| 5 years | 97.4 | 398 | |
| 10 years | 21.5 | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 21/08/2016 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 07/10/2005 |
| Compliance Officer | - | 03/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 12/12/2005 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 07/10/2005 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 21/08/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.98% | +5.13% | -3.49% | +16.08% | 5.78M | ||
| -0.85% | +1.50% | +83.17% | +124.88% | 1,088B | ||
| +0.47% | +1.98% | +50.26% | +51.11% | 629B | ||
| +0.83% | +2.87% | +24.52% | +64.76% | 440B | ||
| -0.88% | -0.66% | +47.04% | +36.64% | 359B | ||
| -0.37% | -0.58% | +28.59% | +36.31% | 291B | ||
| +0.05% | -2.73% | +5.61% | +6.15% | 245B | ||
| +0.40% | +3.21% | +44.42% | +60.11% | 225B | ||
| -0.42% | +1.34% | -6.94% | -51.94% | 204B | ||
| +1.67% | +5.56% | +14.98% | +73.00% | 168B | ||
| Average | +0.49% | +1.16% | +28.82% | +41.71% | 364.92B | |
| Weighted average by Cap. | -0.25% | +1.93% | +46.73% | +64.91% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.56M 3.09M 2.89M 2.64M 4.96M 5.04M 34.07M 13.3M 170M 13.37M 13.08M 568M | 357M 3.74M 3.24M 3.04M 2.77M 5.22M 5.3M 35.81M 13.98M 179M 14.05M 13.75M 597M |
| Net income | 42.46M 445K 386K 362K 330K 620K 630K 4.26M 1.66M 21.26M 1.67M 1.63M 70.91M | 57.89M 607K 526K 493K 449K 846K 859K 5.8M 2.27M 28.98M 2.28M 2.23M 96.67M |
| Net Debt | -36.87M -386K -335K -314K -286K -539K -547K -3.7M -1.44M -18.46M -1.45M -1.42M -61.57M | -32.39M -339K -294K -276K -251K -473K -481K -3.25M -1.27M -16.22M -1.27M -1.25M -54.09M |
Employees
42
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | ₹182.25 | +4.98% | 3,386 |
| 12/08/26 | ₹173.60 | -4.51% | 3,295 |
| 11/08/26 | ₹181.80 | +0.44% | 996 |
| 10/08/26 | ₹181.00 | +1.63% | 366 |
| 07/08/26 | ₹178.10 | +2.18% | 1,083 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
















